KN

Kabir Nath

Chief Executive Officer

Compass Pathways

Therapeutic Areas

Compass Pathways Pipeline

DrugIndicationPhase
COMP360 Psilocybin TherapyTreatment-Resistant Depression (TRD)Phase 3